Vault-13

First Turn Management, LLC

DEL MAR, CA · CIK 1993440 · 13F filing filed 2024-05-06

SEC-registered investment adviser since 2023 · limited liability company

As an employer

$668.5m reported value -4.0% vs Q4 2023
34positions
42.1%in top 10
9 new 10 added 11 reduced 6 sold out vs Q4 2023

Holdings, Q1 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SHOCKWAVE MED INC COM SWAV SWAV 98,111 $31.9m4.78% 4.78% AddedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 57.5k, Q1 2024 98.1k +40.6k +40,627 70.7%
2 ARGENX SE SPONSORED ADR ARGX ARGX 79,978 $31.5m4.71% 4.71% ReducedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 83.4k, Q1 2024 80.0k -3.4k -3,425 -4.1%
3 CYTOKINETICS INC COM NEW CYTK CYTK 430,349 $30.2m4.51% 4.51% ReducedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 807.4k, Q1 2024 430.3k -377.1k -377,095 -46.7%
4 XENON PHARMACEUTICALS INC COM XENE XENE 680,389 $29.3m4.38% 4.38% UnchangedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 680.4k, Q1 2024 680.4k
5 SAREPTA THERAPEUTICS INC COM SRPT SRPT 221,748 $28.7m4.29% 4.29% AddedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 203.9k, Q1 2024 221.7k +17.9k +17,866 8.8%
6 AXSOME THERAPEUTICS INC COM AXSM AXSM 342,173 $27.3m4.08% 4.08% AddedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 295.4k, Q1 2024 342.2k +46.7k +46,745 15.8%
7 DEXCOM INC COM DXCM DXCM 192,932 $26.8m4.00% 4.00% UnchangedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 192.9k, Q1 2024 192.9k
8 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 394,674 $25.7m3.84% 3.84% AddedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 343.1k, Q1 2024 394.7k +51.6k +51,595 15.0%
9 APOGEE THERAPEUTICS INC COM COM 379,803 $25.2m3.78% 3.78% NewShares held: Q2 2023 —, Q3 2023 —, Q4 2023 0, Q1 2024 379.8k
10 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 58,832 $24.6m3.68% 3.68% ReducedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 81.7k, Q1 2024 58.8k -22.9k -22,851 -28.0%
11 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 958,654 $24.1m3.60% 3.60% AddedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 836.3k, Q1 2024 958.7k +122.4k +122,352 14.6%
12 BIOHAVEN LTD COM BHVN BHVN 432,342 $23.6m3.54% 3.54% ReducedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 477.3k, Q1 2024 432.3k -45.0k -44,972 -9.4%
13 KRYSTAL BIOTECH INC COM KRYS KRYS 130,850 $23.3m3.48% 3.48% ReducedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 242.2k, Q1 2024 130.8k -111.3k -111,335 -46.0%
14 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 151,587 $22.9m3.43% 3.43% UnchangedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 151.6k, Q1 2024 151.6k
15 TRANSMEDICS GROUP INC COM TMDX TMDX 297,377 $22.0m3.29% 3.29% ReducedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 323.2k, Q1 2024 297.4k -25.8k -25,808 -8.0%
16 DAY ONE BIOPHARMACEUTICALS I COM COM 1,318,207 $21.8m3.26% 3.26% ReducedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 1.7m, Q1 2024 1.3m -382.7k -382,742 -22.5%
17 NUVALENT INC COM COM 265,897 $20.0m2.99% 2.99% AddedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 255.9k, Q1 2024 265.9k +10.0k +10,000 3.9%
18 IONIS PHARMACEUTICALS INC COM IONS IONS 421,487 $18.3m2.73% 2.73% AddedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 356.7k, Q1 2024 421.5k +64.8k +64,808 18.2%
19 VAXCYTE INC COM PCVX PCVX 260,281 $17.8m2.66% 2.66% ReducedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 357.5k, Q1 2024 260.3k -97.2k -97,247 -27.2%
20 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 464,435 $17.6m2.64% 2.64% NewShares held: Q2 2023 —, Q3 2023 —, Q4 2023 0, Q1 2024 464.4k
21 IDEAYA BIOSCIENCES INC COM IDYA IDYA 397,782 $17.5m2.61% 2.61% AddedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 382.4k, Q1 2024 397.8k +15.4k +15,400 4.0%
22 IMMUNOVANT INC COM IMVT IMVT 512,893 $16.6m2.48% 2.48% UnchangedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 512.9k, Q1 2024 512.9k
23 DISC MEDICINE INC COM IRON IRON 252,673 $15.7m2.35% 2.35% AddedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 157.3k, Q1 2024 252.7k +95.4k +95,399 60.7%
24 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 973,130 $15.7m2.34% 2.34% ReducedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 1.2m, Q1 2024 973.1k -233.2k -233,161 -19.3%
25 ORIC PHARMACEUTICALS INC COM ORIC ORIC 1,097,571 $15.1m2.26% 2.26% NewShares held: Q2 2023 —, Q3 2023 —, Q4 2023 0, Q1 2024 1.1m
26 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 206,707 $14.3m2.14% 2.14% ReducedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 217.4k, Q1 2024 206.7k -10.7k -10,718 -4.9%
27 KALVISTA PHARMACEUTICALS INC COM KALV KALV 1,179,420 $14.0m2.09% 2.09% NewShares held: Q2 2023 —, Q3 2023 —, Q4 2023 0, Q1 2024 1.2m
28 ALPHATEC HLDGS INC COM NEW ATEC ATEC 990,618 $13.7m2.04% 2.04% NewShares held: Q2 2023 —, Q3 2023 —, Q4 2023 0, Q1 2024 990.6k
29 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 228,251 $12.8m1.92% 1.92% ReducedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 476.1k, Q1 2024 228.3k -247.8k -247,828 -52.1%
30 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 585,447 $12.1m1.81% 1.81% AddedShares held: Q2 2023 —, Q3 2023 —, Q4 2023 317.0k, Q1 2024 585.4k +268.4k +268,437 84.7%
31 VIKING THERAPEUTICS INC COM VKTX VKTX 128,064 $10.5m1.57% 1.57% NewShares held: Q2 2023 —, Q3 2023 —, Q4 2023 0, Q1 2024 128.1k
32 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 250,870 $6.8m1.01% 1.01% NewShares held: Q2 2023 —, Q3 2023 —, Q4 2023 0, Q1 2024 250.9k
33 TYRA BIOSCIENCES INC COM TYRA TYRA 381,210 $6.3m0.94% 0.94% NewShares held: Q2 2023 —, Q3 2023 —, Q4 2023 0, Q1 2024 381.2k
34 VERA THERAPEUTICS INC CL A VERA VERA 118,260 $5.1m0.76% 0.76% NewShares held: Q2 2023 —, Q3 2023 —, Q4 2023 0, Q1 2024 118.3k

Sold out since Q4 2023

SecurityTickerShares held beforeValue then
CYMABAY THERAPEUTICS INC CBAY CBAY 1,497,331 $35.4m1.5m shares
KARUNA THERAPEUTICS INC 87,369 $27.7m87.4k shares
INSULET CORP PODD PODD 115,366 $25.0m115.4k shares
ROIVANT SCIENCES LTD ROIV ROIV 1,363,504 $15.3m1.4m shares
CABALETTA BIO INC CABA CABA 175,359 $4.0m175.4k shares
SOMALOGIC INC 17,953 $2.2k18.0k shares